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Automated workflows in clinical and commercial cell line development (CLD) increase efficiency, consistency 
and create flexible resourcing.  We have leveraged our targeted integration host to develop a consistent CLD 
process, which is automatable.  We had previously developed automated single-cell cloning (SCC) and hit-
picking workflows based on plate imaging to produce clonally-derived cell lines.  We have augmented the SCC 
workflow with the addition of single-cell deposition using the Cytena Single-Cell Printer (SCP).  With the 
implementation of the SCP, we gained significant efficiencies when compared to limited dilution SCC by 
processing and imaging 10-times fewer plates and storing 10-times fewer images.  We have also developed 
custom seed train automation, which can passage seed train cultures and set-up and sample fed-batch cultures 
in an unattended operation.  We will discuss details on the SCP implementation as well as the automated CLD 
workflow from transfection, bulk selection, SCC, hit-picking, clone scale-up, seed train passage and fed-batch 
cultures.  We believe that with a very limited staff, we can generate 50 – 200 cell lines per year with our 
automated CLD workflow.     
 
